References
- Boulassel MR, Herr AL, Edwards MD, et al. Early lymphocyte recovery following autologous peripheral blood stem cell transplantation is associated with better survival in younger patients with lymphoproliferative disorders. Hematology 2006;11:165–170.
- Shen HQ, Feng JH, Tang YM, et al. Absolute lymphocyte count is associated with minimal residual disease level in childhood B-cell precursor acute lymphoblastic leukemia. Leuk Res 2013;37:671–674.
- Shin SJ, Roh J, Kim M, et al. Prognostic significance of absolute lymphocyte count/absolute monocyte count ratio at diagnosis in patients with multiple myeloma. Korean J Pathol 2013;47:526–533.
- Porrata LF, Gertz MA, Litzow MR, et al. Early lymphocyte recovery predicts superior survival after autologous hematopoietic stem cell transplantation for patients with primary systemic amyloidosis. Clin Cancer Res 2005;11:1210–1218.
- Kim H, Sohn HJ, Kim S, et al. Early lymphocyte recovery predicts longer survival after autologous peripheral blood stem cell transplantation in multiple myeloma. Bone Marrow Transplant 2006;37:1037–1042.
- Behl D, Porrata LF, Markovic SN, et al. Absolute lymphocyte count recovery after induction chemotherapy predicts superior survival in acute myelogenous leukemia. Leukemia 2006;20:29–34.
- Hasenclever D, Diehl V. A prognostic score for advanced Hodgkin's disease. International Prognostic Factors Project on Advanced Hodgkin's Disease. N Engl J Med 1998;339:1506–1514.
- Ege H, Gertz MA, Markovic SN, et al. Prediction of survival using absolute lymphocyte count for newly diagnosed patients with multiple myeloma: a retrospective study. Br J Hematol 2007;141:749–790.
- Witzig TE, Reeder CB, Polikoff J, et al. Initial results from an international study in relapse/refractory aggressive non-Hodgkin's lymphoma to confirm the activity, safety and criteria for predicting response to lenalidomide monotherapy. Blood 2007;110(Suppl. 1): Abstract 2572.
- D’Agostino RB, Belanger A, D’Agostino RB Jr. A suggestion for using powerful and informative tests of normality. Am Stat 1990;44: 316–321.
- Kaplan E, Meier P. Nonparametric estimation from in-complete observations. J Am Stat Assoc 1958;53:457–481.
- Mahindra A, Laubach J, Raje N, et al. Latest advances and current challenges in the treatment of multiple myeloma. Nat Rev Clin Oncol 2012;9:135–143.
- Chanan-Khan A, Miller KC, Takeshita K, et al. Results of a phase 1 clinical trial of thalidomide in combination with fludarabine as initial therapy for patients with treatment requiring chronic lymphocytic leukemia (CLL). Blood 2005;106;3348–3352.
- Song MK, Chung JS, Joo YD, et al. Clinical value of absolute lymphocyte counts before bortezomib-dexamethasone therapy in relapsed multiple myeloma patients. Acta Haematol 2010;124:34–39.